2019
DOI: 10.1002/biot.201800647
|View full text |Cite
|
Sign up to set email alerts
|

High‐Affinity Antibody Detection with a Bivalent Circularized Peptide Containing Antibody‐Binding Domains

Abstract: Direct chemical labeling of antibody produces molecules with poorly defined modifications. Use of a small antibody-binding protein as an adapter can simplify antibody functionalization by forming a specific antibody-bound complex and introducing site-specific modifications. To stabilize a noncovalent antibody complex that may be used without chemical crosslinking, a bivalent antibody-binding protein is engineered with an improved affinity of interaction by joining two Z domains with a conformationally flexible… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(8 citation statements)
references
References 65 publications
1
7
0
Order By: Relevance
“…Upon treatment with sortase A, a native peptide bond is formed between Thr 146 and Gly 1 , and the cyclic dimer, (Z HER2 ) 2:C , is formed ( Figure 2 B). For reference, the designs of three cyclic Affibody variants described earlier in the literature [ 24 , 25 , 26 ] are schematically shown ( Figure 2 C). It can be noted that the two previously described cyclic HER2-binding Affibody molecules are monomeric or truncated versions of the protein, not taking advantage of the possible avidity effects that are expected from dimeric constructs.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Upon treatment with sortase A, a native peptide bond is formed between Thr 146 and Gly 1 , and the cyclic dimer, (Z HER2 ) 2:C , is formed ( Figure 2 B). For reference, the designs of three cyclic Affibody variants described earlier in the literature [ 24 , 25 , 26 ] are schematically shown ( Figure 2 C). It can be noted that the two previously described cyclic HER2-binding Affibody molecules are monomeric or truncated versions of the protein, not taking advantage of the possible avidity effects that are expected from dimeric constructs.…”
Section: Resultsmentioning
confidence: 99%
“…Zhou and coworkers used split-intein technology to produce a dimeric and backbone-cyclized Z-domain capable of binding to human IgG1 with increased affinity compared to the original monomeric protein [ 24 ], suggesting that the two domains can bind simultaneously on opposite sides of the symmetrical IgG1 dimer. A linear precursor protein, with a 17-residue linker separating the two Z-domains, showed a 10–12-fold higher affinity for human IgG1 compared to monomeric Z, and importantly, the subsequent backbone cyclization reaction, in which a significantly longer second 45–54 residue linker was formed, did not have a detrimental effect on the antibody binding affinity according to SPR and flow cytometry data [ 26 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…It was also equipped with an N-terminal biotinylation tag as well as a cysteine for additional reporter conjugation. The lasso was used as a capturing agent in an ELISA and shown to lower the limit of detection compared to an immobilized secondary Fab fragment by 12-fold and also, when conjugated to a fluorophore, used as a detecting agent in a confocal microscopy cell detection assay …”
Section: Affinity Ligands and Their Role In Site-specific Conjugation...mentioning
confidence: 99%